Taddese Menassie sold XERS
November 2, 2026 · Form 4 insider transaction
Taddese Menassie sold 31,499 shares of Xeris Biopharma Holdings, Inc. at $10.17 per share, a transaction worth $320.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
31,499
Price
$10.17
Total value
$320.3K
InsiderTaddese Menassie
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateNovember 2, 2026
Filing dateNovember 4, 2026
Shares owned after31,499
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service on the Company's Board of Directors through such vesting date.